How much revenue does Minerva Surgical make?

Minerva Surgical reported $50.29 million in revenue for fiscal year 2022, down 3.5% from $52.10 million in fiscal year 2021. In Q3 2023 revenue was $11.97 million.

What companies are similar to Minerva Surgical?

Listed companies of a similar size in the same industry (targeted healthcare equipment) include Micron Solutions INC (MICR), American Scientific Resources, Incorporated (ASFX), Micro Imaging Technology, Inc. (MMTC), Bionovate Technologies Corp (BIIO).

Minerva Surgical, Inc. (UTRS) Stock

About Minerva Surgical, Inc.

Minerva Surgical, Inc. provides a suite of devices to treat the root causes of abnormal uterine bleeding in the United States. The company provides Minerva Endometrial Ablation System, a technology that uses three methods of tissue ablation; Symphion System that is designed for fluid management, direct intrauterine pressure monitoring, and bladeless resection work; and Genesys HTA, an endometrial ...

At a glance

Minerva Surgical reported revenue of $50.29 million for fiscal year 2022, down 3.5% from fiscal year 2021, and net income of -$34.11 million. In Q3 2023 (the quarter ended September 30, 2023) revenue was $11.97 million, down 4.9% from a year before.

Figures from company filings; latest fiscal year ended December 31, 2022.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.